Nirvana Life Sciences Inc. Announces the appointment of Andrew Samann to Advisory Board Psychedelics Investing
Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia Pharmaceutical Investing
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT Pharmaceutical Investing
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
